Is boost therapy necessary in the treatment of DCIS? No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2008 ASCO Annual Meeting. This abstract does not ...
Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results